Related references
Note: Only part of the references are listed.STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
Dan Turner et al.
GASTROENTEROLOGY (2021)
Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis
Mark A. Samaan et al.
GASTROINTESTINAL ENDOSCOPY (2018)
Prognostic value of histological activity in patients with ulcerative colitis in deep remission: A prospective multicenter study
Triana Lobaton et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)
Pouch-Related Symptoms and Quality of Life in Patients with Ileal Pouch-Anal Anastomosis
Edward L. Barnes et al.
INFLAMMATORY BOWEL DISEASES (2017)
Noninvasive Fecal Immunochemical Testing and Fecal Calprotectin Predict Mucosal Healing in Inflammatory Bowel Disease: A Prospective Cohort Study
Christopher Ma et al.
INFLAMMATORY BOWEL DISEASES (2017)
Impact of Histological and Endoscopic Remissions on Clinical Recurrence and Recurrence-free Time in Ulcerative Colitis
Ana Ponte et al.
INFLAMMATORY BOWEL DISEASES (2017)
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
Jean-Frederic Colombel et al.
LANCET (2017)
Histological Disease Activity as a Predictor of Clinical Relapse Among Patients With Ulcerative Colitis: Systematic Review and Meta-Analysis
Sunhee Park et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Histology Grade Is Independently Associated With Relapse Risk in Patients With Ulcerative Colitis in Clinical Remission: A Prospective Study
Talia Zenlea et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Correlation Between Concentrations of Fecal Calprotectin and Outcomes of Patients With Ulcerative Colitis in a Phase 2 Trial
William J. Sandborn et al.
GASTROENTEROLOGY (2016)
Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease
Eran Zittan et al.
INFLAMMATORY BOWEL DISEASES (2016)
Consecutive Monitoring of Fecal Calprotectin and Lactoferrin for the Early Diagnosis and Prediction of Pouchitis after Restorative Proctocolectomy for Ulcerative Colitis
Takayuki Yamamoto et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis
Klaus Theede et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Clinical Utility of Fecal Biomarkers for the Diagnosis and Management of Inflammatory Bowel Disease
Uri Kopylov et al.
INFLAMMATORY BOWEL DISEASES (2014)
Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes
Alain M. Schoepfer et al.
INFLAMMATORY BOWEL DISEASES (2013)
Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta-analysis of prospective studies
Ren Mao et al.
INFLAMMATORY BOWEL DISEASES (2012)
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
Geert D'Haens et al.
INFLAMMATORY BOWEL DISEASES (2012)
Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment
Taina Sipponen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis
Matt W. Johnson et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2008)
Comprehensive pouch clinic concept for follow-up of patients after ileal pouch anal anastomosis: Report of 3 years' experience in a tertiary referral center
Hagit Tulchinsky et al.
INFLAMMATORY BOWEL DISEASES (2008)
Diagnosis and management of pouchitis
U Mahadevan et al.
GASTROENTEROLOGY (2003)
Assessment of ileal pouch inflammation by single-stool calprotectin assay
P Thomas et al.
DISEASES OF THE COLON & RECTUM (2000)